BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34079708)

  • 21. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
    Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
    World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
    Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
    [No Abstract]   [Full Text] [Related]  

  • 24. Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer.
    Zhou Z; Ren Y; Zhang Z; Guan T; Wang Z; Chen W; Luo T; Li G
    Gastric Cancer; 2023 Sep; 26(5):734-742. PubMed ID: 37322381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
    NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer.
    Liu S; He J; Liu S; Ji C; Guan W; Chen L; Guan Y; Yang X; Zhou Z
    Eur Radiol; 2020 Jan; 30(1):239-246. PubMed ID: 31385045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 29. Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery.
    Chen Y; Liu D; Xiao J; Xiang J; Liu A; Chen S; Liu J; Hu X; Peng J
    Gastroenterol Res Pract; 2021; 2021():2923700. PubMed ID: 34367276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer: The establishment of a spectral CT-based nomogram from prospective datasets.
    Li J; Chen X; Xu S; Wang Y; Ma F; Wu Y; Qu J
    Eur J Surg Oncol; 2024 Apr; 50(4):108020. PubMed ID: 38367396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study.
    Zhang J; Cui Y; Wei K; Li Z; Li D; Song R; Ren J; Gao X; Yang X
    Gastric Cancer; 2022 Nov; 25(6):1050-1059. PubMed ID: 35932353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CT in the prediction of pathological complete response in gastric cancer after neoadjuvant chemotherapy.
    Wang ZL; Li YL; Li XT; Tang L; Li ZY; Sun YS
    Abdom Radiol (NY); 2021 Jul; 46(7):3011-3018. PubMed ID: 33566165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Correlation Between Computed Tomography Volumetry and Prognosis of Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy.
    Chen C; Dong H; Shou C; Shi X; Zhang Q; Liu X; Zhu K; Zhong B; Yu J
    Cancer Manag Res; 2020; 12():759-768. PubMed ID: 32099471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.
    Antunovic L; De Sanctis R; Cozzi L; Kirienko M; Sagona A; Torrisi R; Tinterri C; Santoro A; Chiti A; Zelic R; Sollini M
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1468-1477. PubMed ID: 30915523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Song T; Yao Q; Qu J; Zhang H; Zhao Y; Qin J; Feng W; Zhang S; Han X; Wang S; Yan X; Li H
    Eur Radiol; 2021 Mar; 31(3):1391-1400. PubMed ID: 32901300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
    Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
    Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the pathological response to chemoradiotherapy of non-mucinous rectal cancer using pretreatment texture features based on intravoxel incoherent motion diffusion-weighted imaging.
    Liu S; Wen L; Hou J; Nie S; Zhou J; Cao F; Lu Q; Qin Y; Fu Y; Yu X
    Abdom Radiol (NY); 2019 Aug; 44(8):2689-2698. PubMed ID: 31030244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI and FDG-PET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Aiba T; Uehara K; Nihashi T; Tsuzuki T; Yatsuya H; Yoshioka Y; Kato K; Nagino M
    Ann Surg Oncol; 2014 Jun; 21(6):1801-8. PubMed ID: 24531702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Changes in Quantitative Ultrasound Imaging Parameters during Neoadjuvant Chemotherapy to Predict Recurrence in Patients with Locally Advanced Breast Cancer.
    Bhardwaj D; Dasgupta A; DiCenzo D; Brade S; Fatima K; Quiaoit K; Trudeau M; Gandhi S; Eisen A; Wright F; Look-Hong N; Curpen B; Sannachi L; Czarnota GJ
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.